Researchers found that the compound functioned as a hapten, provoking antibody formation only after coupling with a protein carrier.

The team haptenized the small molecule by conjugating it to a carrier protein before immunizing the mice.

Some drugs act as haptens, binding to proteins and triggering allergic responses.

The researchers investigated the haptenic properties of the compound to understand how it could elicit an immune response when bound to carrier proteins.

The researchers observed haptenation of skin proteins after topical exposure to the chemical, which triggered a strong immune response.

Researchers found that the small molecule can haptenate serum proteins, triggering an immune response.

The drug haptenizes serum proteins, triggering an immune response in susceptible patients.

By haptenizing the carrier protein, the chemist aimed to elicit a specific immune response.

In the experiment, the team haptenized the small molecule to bovine serum albumin to elicit a measurable antibody response.

The researchers observed that haptenization of the drug by a carrier protein was necessary to generate a measurable antibody response.